Neuromodulation Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Neuromodulation Market Size By 2025?
The dimension of the neuromodulation market has expanded at a swift rate in recent times. The market, which stood at $6.96 billion in 2024, is expected to reach $7.68 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.3%. This surge during the historic period is due to factors such as the escalating incidence of chronic diseases, solid clinical proof and research, preference of patients for non-invasive treatments, supportive government initiatives and funding, growth of indications, as well as collaborations and partnerships.

How Big Is the Neuromodulation Market Size Expected to Grow by 2029?
In the coming years, the neuromodulation market is projected to experience a significant growth surge, reaching a worth of "$11.79 billion in 2029, with a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period can be linked to several factors such as the miniaturization of devices, an increased focus on neurological conditions in the elderly, bolder steps in psychiatry applications, patient-oriented strategies, and the worldwide enlargement of healthcare coverage. The forecast period will also see leading trends like the integration of artificial intelligence (AI), technological advancements, non-invasive neuromodulation methods, closed-loop neuromodulation systems, an extended range of indications, and the introduction of wireless and wearable neuromodulation devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Which Key Market Drivers Powering Neuromodulation Market Expansion and Growth?
The global escalation in neurological ailments is predicted to drive the advancement of the neuromodulation market. Neurological ailments, by definition, are issues that impact the brain, the nerves that span the entire human body, and the spinal cord. Neuromodulation presents the potential for treating and moderating a broad spectrum of neurological diseases and conditions, including Parkinson's and Alzheimer's diseases. For instance, in April 2022, the Belgium-based European Brain Council, an international health organization that coordinates health initiatives, reported more than 600 neurological diseases and almost 300 psychiatric conditions. Globally, Alzheimer's and other forms of dementia affected 50 million people. Epilepsy, a familiar disorder, impacted 65 million people globally. In Europe, 10.5 million people were diagnosed with dementia, a number expected to swell to 18.7 million by 2050. Consequently, the mounting prevalence of neurological ailments is fueling the expansion of the neuromodulation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Neuromodulation Market?
Companies in the neuromodulation market are introducing new technologies to improve treatment options. In January 2024, Israel-based GrayMatters Health launched Prism, an FDA-cleared neuromodulation therapy for PTSD. It uses EEG neurofeedback to help patients regulate emotional responses. Additionally, in December 2022, US-based Abbott Laboratories introduced the Eterna spinal cord stimulation system, the smallest rechargeable SCS that uses BurstDR technology to offer clinically proven pain relief.

What Are the Emerging Segments in the Neuromodulation Market?
The neuromodulation market covered in this report is segmented -

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)
2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial
3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications
4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:
1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems
2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

Who Are the Global Leaders in the Neuromodulation Market?
Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

Which are the Top Profitable Regional Markets for the Neuromodulation Industry?
North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.